SSTR2 and neoplasm: The expression of SSTR2 in all tested tumor cells was identical to previous reports that SSTR2 is abberantly expressed in these tumor tissues, thus confirming that SSTR2 could be used as a specific target for JF-10-81 to treat these receptor-positive tumors.